NASDAQ:INMD - InMode Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $47.75
  • Forecasted Upside: 15.09 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$41.49
▼ -0.31 (-0.74%)
1 month | 3 months | 12 months
Get New InMode Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INMD

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$47.75
▲ +15.09% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for InMode in the last 3 months. The average price target is $47.75, with a high forecast of $55.00 and a low forecast of $38.00. The average price target represents a 15.09% upside from the last price of $41.49.
Buy
The current consensus among 4 polled investment analysts is to buy stock in InMode.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/3/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/1/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/21/2020Canaccord GenuityBoost Price TargetBuy$42.00 ➝ $51.00Medium
i
10/14/2020UBS GroupBoost Price TargetBuy$43.00 ➝ $47.00High
i
10/13/2020Robert W. BairdBoost Price TargetOutperform$43.00 ➝ $55.00High
i
8/17/2020BarclaysBoost Price TargetOverweight$36.00 ➝ $38.00High
i
5/7/2020Canaccord GenuityLower Price TargetBuy$50.00 ➝ $40.00Low
i
5/7/2020UBS GroupLower Price TargetBuy$46.00 ➝ $42.00Low
i
3/26/2020BarclaysLower Price TargetOverweight$48.00 ➝ $36.00Low
i
2/19/2020BarclaysBoost Price TargetOverweight$45.00 ➝ $48.00High
i
2/19/2020Canaccord GenuityReiterated RatingBuy$50.00High
i
1/28/2020Robert W. BairdReiterated RatingOutperform$45.00 ➝ $55.00Medium
i
Rating by Jeff Johnson at Robert W. Baird
11/6/2019BarclaysBoost Price TargetOverweight$27.00 ➝ $45.00High
i
11/6/2019Robert W. BairdReiterated RatingOutperform$27.00 ➝ $45.00High
i
Rating by Jeff Johnson at Robert W. Baird
9/3/2019BarclaysInitiated CoverageOverweight$27.00High
i
9/3/2019Robert W. BairdInitiated CoverageOutperform$27.00High
i
9/3/2019Canaccord GenuityInitiated CoverageBuy$30.00High
i
9/3/2019UBS GroupInitiated CoverageBuy$28.00High
i
(Data available from 10/26/2015 forward)
InMode logo
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, and India, as well as indirectly through third-party distributors internationally. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.
Read More

Today's Range

Now: $41.49
$40.62
$42.12

50 Day Range

MA: $36.85
$32.07
$42.01

52 Week Range

Now: $41.49
$13.14
$58.76

Volume

470,000 shs

Average Volume

1,043,347 shs

Market Capitalization

$1.33 billion

P/E Ratio

33.46

Dividend Yield

N/A

Beta

2.12